BRCA2 and posterior cortical atrophy: The National Comprehensive Cancer Network (NCCN) PCa Early Detection guidelines recommend PCa screening at age 40 years for BRCA2 carriers, and consider for individuals with other germline mutations beginning shared decision-making about PSA screening at age 40 years and screening at annual intervals rather than every other year [113].